Tonghua Dongbao Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600867.SS

Tonghua Dongbao Pharmaceutical Co., Ltd. Revenue for the year ending December 31, 2023: USD 433.17 M

Tonghua Dongbao Pharmaceutical Co., Ltd. Revenue is USD 433.17 M for the year ending December 31, 2023, a 7.59% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Tonghua Dongbao Pharmaceutical Co., Ltd. Revenue for the year ending December 31, 2022 was USD 402.63 M, a -21.71% change year over year.
  • Tonghua Dongbao Pharmaceutical Co., Ltd. Revenue for the year ending December 31, 2021 was USD 514.30 M, a 16.07% change year over year.
  • Tonghua Dongbao Pharmaceutical Co., Ltd. Revenue for the year ending December 31, 2020 was USD 443.08 M, a 11.10% change year over year.
  • Tonghua Dongbao Pharmaceutical Co., Ltd. Revenue for the year ending December 31, 2019 was USD 398.80 M, a 1.85% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
SV Wall Street
Shanghai Stock Exchange: 600867.SS

Tonghua Dongbao Pharmaceutical Co., Ltd.

CEO Mr. Sheng Leng Chun
IPO Date Aug. 24, 1994
Location China
Headquarters Dongbao New Village
Employees 3,196
Sector Healthcare
Industries
Description

Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro; antidiabetic drugs; and oral hypoglycemic drugs, as well as Gan Shulin pens, blood glucose meters, and other medical devices. It offers building materials. The company has a strategic alliance with Adocia. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.

Similar companies

600886.SS

SDIC Power Holdings Co., Ltd.

USD 1.99

1.46%

600535.SS

Tasly Pharmaceutical Group Co., Ltd

USD 2.04

1.42%

600893.SS

AECC Aviation Power Co.,Ltd

USD 5.15

-0.07%

StockViz Staff

February 2, 2025

Any question? Send us an email